Roots Analysis has announced the addition of In Silico Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery / Multi-Target Drug Design, Interface Based Drug Discovery, Approaches)” report to its list of offerings.
Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules against hundreds of biological targets, thereby, allowing significant reductions in the investment of both time and resources.
To order this 290+ page report, which features 120+ figures and 135+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
The USD 124 million (by 2030) financial opportunity within the in silico drug discovery market for large molecules has been analyzed across the following segments:
- Key Drug Discovery Steps
- Target Identification
- Target Validation
- Hit Generation
- Hit-to-Lead
- Lead Optimization
- Type of Large Molecule
- Antibodies
- Proteins
- Peptides
- Nucleic Acids
- Vectors
- Company Size
- Small
- Mid-sized
- Large
- Target therapeutic Area
- Autoimmune Disorders
- Blood Disorders
- Cardiovascular Disorders
- Gastrointestinal and Digestive Disorders
- Hormonal Disorders
- Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS)
- Infectious Diseases
- Metabolic Disorders
- Mental Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Oncological Disorders
- Respiratory Disorders
- Skin Disorders
- Urogenital Disorders
- Others
- Type of Sponsor
- Industry Players
- Non-Industry Players
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030, report features the following companies, which we identified to be key players in this domain:
- Abzena
- BioDuro
- BioNTech
- ChemPartner
- Creative Biostructure
- GenScript
- LakePharma
- Sundia MediTech
- Sygnature Discovery
- Viva Biotech
Table of Contents
- Preface
2. Executive Summary
- Introduction
- Market Landscape
- Key Insights
- Company Profiles
- Company Competitiveness Analysis
- Key Opportunity Areas
- Emerging Business Models and Strategies
- Case study: comparison of drug discovery processes of small molecules and large molecules
- Survey insights
- Cost saving analysis
- Market Forecast
- In silico tools and upcoming trends in drug discovery
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
- Appendix 3: Non-Computational Methods for Drug Discovery
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook – https://www.facebook.com/RootsAnalysis
LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter – https://twitter.com/RootsAnalysis
Medium – https://medium.com/@RootsAnalysis
Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/
Quora – https://rootsanalysisinsights.quora.com/
